Hemolysis detection device, system and method

Patent metadata

Field	Value
Publication number	US-10386374-B2
Application number	US-201515513429-A
Country	US
Kind code	B2
Filing date	Sep 29, 2015
Priority date	Sep 30, 2014
Publication date	Aug 20, 2019
Grant date	Aug 20, 2019

Abstract

Aspects of the present invention are directed to devices, systems and methods that enable the quick and reliable detection of hemolysis in a sample such that a sample which exhibits an unacceptable level of hemolysis can be flagged or disregarded in an associated diagnostic test.

First claim

The invention claimed is:

1. A diagnostic system comprising:
a device comprising a plasma separation membrane configured to separate a plasma fraction from a first blood sample from a first sample source by flow of the plasma fraction through the plasma separation membrane, wherein the plasma fraction comprises plasma and an amount of hemoglobin upon an occurrence of hemolysis in the first sample;
a detection system configured for receipt of the device thereon or therein and for determining the amount of hemoglobin in the plasma fraction, and
a diagnostic instrument in communication with the detection system configured for analyzing a second blood sample from the first sample source for one or more analytes,
wherein the device comprises:
a body with an upper portion and a lower portion;
an opening defined in the body for introduction of the first blood sample, wherein. the plasma separation membrane receives the blood sample from the opening; and
a second membrane positioned below the plasma separation membrane so as to receive the plasma fraction from the plasma separation membrane,
wherein the device further comprises a slit in the lower portion of the body defining a pathway for energy to be applied to the second membrane from the detection system,
wherein the detection system comprises a detector for receiving and measuring energy transmitted from the second membrane or energy absorbed by the second membrane.

2. The diagnostic system of claim 1 , wherein the diagnostic instrument is configured to analyze the second blood sample for the one or more analytes only when the amount of hemoglobin in the first sample is determined to be below a predetermined threshold value for hemolysis by the detection system.

3. The system of claim 1 , wherein the detection system is configured for plug in communication with the diagnostic instrument.

4. The system of claim 1 , wherein the diagnostic instrument comprises a blood gas analyzer.

5. The diagnostic system of claim 1 , wherein the device is in the form of a cartridge.

6. The diagnostic system of claim 1 , wherein the detection system comprises a receiving space sized for receiving the device therein.

7. The diagnostic system of claim 1 , wherein the detection system comprises:
an energy source configured to direct energy comprising one or more wavelengths onto the second membrane; and
a detector configured to measure one or more transmitted and/or absorbed wavelengths from the second membrane, the one or more transmitted and/or absorbed wavelengths indicative of an amount of hemoglobin in the plasma fraction.

8. The system of claims 7 , wherein the detection system comprises a spectrometer, and wherein the spectrometer is configured to receive a transmission spectrum from the second membrane upon application of the energy to the second membrane from the energy source, and wherein the transmission spectrum is indicative of an amount of hemoglobin in the plasma fraction.

9. The system of claim 1 , wherein the detection system further comprises a computing unit configured to receive data from the detection system and determine an amount of hemoglobin from the data.

10. The system of claim 9 , wherein the computing unit is further configured to provide an indication that a degree of hemolysis is greater than a predetermined threshold value.

11. A method for detecting hemolysis in a whole blood sample comprising:
(a) contacting a first whole blood sample with a plasma separation membrane located in a device to separate a plasma fraction from the whole blood sample, the plasma fraction comprising plasma and an amount of hemoglobin therein upon hemolysis of the sample, wherein the device comprising:
a body with an upper portion and a lower portion;
an opening defined in the body for introduction of the first whole blood sample, wherein the plasma separation membrane receives the blood sample from the opening; and
a second membrane positioned below the plasma separation membrane so as to receive the plasma fraction from the plasma separation membrane, wherein the device further comprises a slit in the lower body portion of the body defining a pathway for energy to be applied to the second membrane from a detection system, wherein the detection system comprises a detector for receiving and measuring energy transmitted from the second membrane or energy absorbed by the second membrane;

(b) contacting the plasma fraction with the second membrane, wherein the plasma fraction is absorbed and/or maintained on the second membrane;
(c) transmitting energy from an energy source in the detection system to the second membrane through the slit in the device;
(d) determining an amount of hemoglobin in the plasma fraction with the detection system, wherein the determining is done by spectroscopy; and
(e) analyzing a second blood sample from a same source as the first blood sample for an analyte in a diagnostic instrument in communication with the detection system when the amount of hemoglobin in the first blood sample is determined to be below a predetermined threshold value for hemolysis by the detection system.

12. The method of claim 11 , wherein the analyte comprises potassium, and wherein the analyzing is done when the amount of hemoglobin is less than a predetermined threshold value.

13. The method of claim 12 , wherein the predetermined threshold value is an amount of hemolysis sufficient to provide for an elevated level of potassium in the second sample upon analysis of the second sample for potassium on the diagnostic instrument.

14. The method of claim 12 , wherein the determining comprises quantitatively determining the amount of hemoglobin in the plasma fraction.

15. The method of claim 11 , wherein an amount of hemolysis corresponds to the amount of hemoglobin in the plasma fraction, and wherein the method further comprises providing an indication that the amount of hemolysis is greater than a predetermined threshold value.

16. The method of claim 15 , wherein the indication comprises at least one of an audio or a visual alarm.

Assignees

• Siemens Healthcare Diagnostics Inc

Inventors

• Baxter Andrew John
• Cotton Paul William

Classifications

• G01N2015/055

  for hematocrite determination · CPC title

• G01N33/483

  Physical analysis of biological material · CPC title

• G01N33/49

  Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

• G01N33/491 Primary

  by separating the blood components (G01N15/05 takes precedence) · CPC title

• G01N33/72

  involving blood pigments, e.g. haemoglobin, bilirubin {or other porphyrins; involving occult blood} · CPC title